Role of thrombolytic agents in cardiac arrest

D K Pedley1, W G Morrison

  • 1Department of Academic Emergency Medicine, James Cook University Hospital, Middlesbrough TS4 3BW, UK. dpedley@doctors.org.uk

Insights

Thrombolytic agents show potential for improving survival in cardiac arrest patients, but current evidence is limited. More research is needed to confirm the effectiveness of thrombolysis in cardiac arrest.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Pharmacology

Background:

  • Cardiac arrest prognosis is typically poor, with limited success in improving patient outcomes.
  • Existing interventions have not reliably increased survival rates after cardiac arrest.
  • Thrombosis is a significant factor in many cardiac arrest cases, suggesting a role for thrombolytic therapy.

Purpose of the Study:

  • To review the current literature on the use of thrombolytic agents during cardiac arrest.
  • To evaluate the potential benefits and limitations of thrombolysis in improving cardiac arrest survival.

Main Methods:

  • A comprehensive literature search was conducted using Medline, Embase, and the Cochrane Library.
  • Databases were searched from 1966 to January 2006 (Medline), 1988 to January 2006 (Embase), and the Cochrane Library.
  • Six relevant articles were selected for in-depth review.

Main Results:

  • Case reports and animal studies suggest favorable outcomes and plausible mechanisms for thrombolysis in cardiac arrest.
  • Some reviewed studies indicate encouraging results regarding thrombolytic therapy.
  • All currently available studies are limited by small sample sizes and design flaws.

Conclusions:

  • Thrombolysis is a suggested intervention for cardiac arrest due to the role of thrombosis.
  • While some findings are encouraging, the current evidence base for thrombolysis in cardiac arrest is insufficient.
  • Further high-quality research is required to establish the efficacy and safety of thrombolytic agents in cardiac arrest management.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...